Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents is a research paper published in RSC Advances (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Russian Science Foundation
Grant: 19-74-10022
National Institutes of Health
Grant: R21 CA223394
National Institutes of Health
Grant: R01 CA218802
National Institutes of Health
Grant: P30 CA060553
National Institutes of Health
Grant: P30 CA006927
Rochester Academy of Science
Grant: 01201354239
National Foundation for Science and Technology Development
Grant: 104.01-2015.68
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 5P30CA006927-49
Transgenic Mouse
National Institutes of Health
Grant: 5R01CA218802-04
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
National Institutes of Health
Grant: 5R21CA223394-02
Targeting Musashi-2 (MSI2) regulation of EGFR and HER2 in lung cancer
Kazan Federal University
FWCI
1.81
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals